Pacific Biosciences of California, Inc. (PACB)

1.40 -9.68% (-0.15)

Over 1Y: +5.3%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1 1.5 2 2.5
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 34.9M Q3 '21 — Operating Cash Flow: -40.7M Q3 '21 — Free Cash Flow: -41.8M Q3 '21 — Net Income: 16.5M Q4 '21 — Revenue: 36M Q4 '21 — Operating Cash Flow: -31.7M Q4 '21 — Free Cash Flow: -34.5M Q4 '21 — Net Income: -69.3M Q1 '22 — Revenue: 33.2M Q1 '22 — Operating Cash Flow: -79M Q1 '22 — Free Cash Flow: -82.7M Q1 '22 — Net Income: -81.5M Q2 '22 — Revenue: 35.5M Q2 '22 — Operating Cash Flow: -60.6M Q2 '22 — Free Cash Flow: -64.6M Q2 '22 — Net Income: -71.4M Q3 '22 — Revenue: 32.3M Q3 '22 — Operating Cash Flow: -63.1M Q3 '22 — Free Cash Flow: -67.2M Q3 '22 — Net Income: -77M Q4 '22 — Revenue: 27.4M Q4 '22 — Operating Cash Flow: -60.6M Q4 '22 — Free Cash Flow: -65.5M Q4 '22 — Net Income: -84.4M Q1 '23 — Revenue: 38.9M Q1 '23 — Operating Cash Flow: -94.7M Q1 '23 — Free Cash Flow: -98.4M Q1 '23 — Net Income: -88M Q2 '23 — Revenue: 47.6M Q2 '23 — Operating Cash Flow: -41.7M Q2 '23 — Free Cash Flow: -44M Q2 '23 — Net Income: -69.8M Q3 '23 — Revenue: 55.7M Q3 '23 — Operating Cash Flow: -65.2M Q3 '23 — Free Cash Flow: -66M Q3 '23 — Net Income: -66.9M Q4 '23 — Revenue: 58.4M Q4 '23 — Operating Cash Flow: -57.6M Q4 '23 — Free Cash Flow: -59.6M Q4 '23 — Net Income: -82M Q1 '24 — Revenue: 38.8M Q1 '24 — Operating Cash Flow: -75.7M Q1 '24 — Free Cash Flow: -79.6M Q1 '24 — Net Income: -78.2M Q2 '24 — Revenue: 36M Q2 '24 — Operating Cash Flow: -54.3M Q2 '24 — Free Cash Flow: -55.7M Q2 '24 — Net Income: -173.3M Q3 '24 — Revenue: 40M Q3 '24 — Operating Cash Flow: -45.5M Q3 '24 — Free Cash Flow: -46.2M Q3 '24 — Net Income: -60.7M Q4 '24 — Revenue: 39.2M Q4 '24 — Operating Cash Flow: -30.6M Q4 '24 — Free Cash Flow: -32.3M Q4 '24 — Net Income: 2.4M Q1 '25 — Revenue: 37.2M Q1 '25 — Operating Cash Flow: -44.1M Q1 '25 — Free Cash Flow: -45.4M Q1 '25 — Net Income: -426.1M Q2 '25 — Revenue: 39.8M Q2 '25 — Operating Cash Flow: -29.4M Q2 '25 — Free Cash Flow: -29.9M Q2 '25 — Net Income: -41.9M Q3 '25 — Revenue: 38.4M Q3 '25 — Operating Cash Flow: -18.7M Q3 '25 — Free Cash Flow: -18.8M Q3 '25 — Net Income: -38M Q4 '25 — Revenue: 44.6M Q4 '25 — Operating Cash Flow: -19.1M Q4 '25 — Free Cash Flow: -19.9M Q4 '25 — Net Income: -40.4M Q1 '26 — Revenue: 37.2M Q1 '26 — Operating Cash Flow: -44.7M Q1 '26 — Free Cash Flow: -47.7M Q1 '26 — Net Income: -8.3M Q2 '26 — Revenue: 39M Q2 '26 — Operating Cash Flow: -35.6M Q2 '26 — Free Cash Flow: -37.1M Q2 '26 — Net Income: -44.7M -400M -300M -200M -100M 0 100M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 21.5%
OE margin -99.0%
Oper. margin -83.5%
Accruals -1.8%
Gross margin 36.4%
EBITDA margin -77.4%
FCF margin -77.5%
OCF margin -74.1%
Profit margin -82.5%
ROA -17.5%
ROCE -19.5%
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.5
RPO / sales 0.3×
RPO growth -15.4%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -18.2×
Debt payback 0.0 yr
Quick ratio 4.0×
Cash runway 1.9 yr
F-score 3.4 pts
Cash / Debt —
Debt / Eq —
Equity / Assets —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.9
Sales/sh Y/Y -1.9%
Sales Q/Q -1.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.